Results 231 to 240 of about 2,458,624 (375)

Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients

, 2021
Anishaa Sivakumar, Lynn M. Madden, Elizabeth DiDomizio, Anthony Eller, Merceditas Villanueva, Frederick L. Altice   +5 more
openalex   +2 more sources

Aligning forces to accelerate healthcare transformation: Insights from the UPMC learning community

Learning Health Systems, EarlyView.
Abstract Introduction To accelerate transformation toward value‐based, equitable care, health systems need a viable approach for engaging and aligning multiple stakeholders to promote innovation. Building and sustaining learning communities offers one possible solution.
Diane Holder, Donna Keyser, Jane Kogan, Matthew O. Hurford, John Lovelace, James Schuster   +5 more
wiley   +1 more source

A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome

, 2021
Ayesha C. Sujan, Emma Cleary, Edie Douglas, Rubin Aujla, Lisa Boyars, Claire Smith, Constance Guille   +6 more
openalex   +1 more source

Consensus-Based Treatment Approaches for Managing Concerning Behaviors in Patients on Long-term Opioid Therapy for Chronic Pain: Case-Based Applications

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
Guidelines recommend careful monitoring of patients on long-term opioid therapy for chronic pain to assess for concerning medication-taking behaviors that may signal opioid misuse or the presence of a substance use disorder.
William C. Becker, MD, E. Jennifer Edelman, MD, MHS, Joanna L. Starrels, MD, MS, Soraya Azari, MD, Payel Roy, MD, Sarah R. Young, PhD, LMSW, Jane Liebschutz, MD, Jessica S. Merlin, MD, PhD   +7 more
doaj  

Medication Assisted Treatment for Opioid Use Disorder [PDF]

, 2020
Anderson, Michael Ray
core   +1 more source

A learning health system model for addressing substance use: Denver Health Center for Addiction Medicine

Learning Health Systems, EarlyView.
Abstract Introduction Substance use disorders (SUDs) continue to place heavy burdens on patients, health systems, and communities. Rapidly evolving treatment for SUDs requires health systems that can efficiently and effectively assess data and integrate evidence to practice.
Emily Bacon, Laura J. Podewils, Brooke Bender, Joshua Blum, Christian Thurstone, Alia Al‐Tayyib, John Mills, Alexandra R. Tillman, Judith Shlay   +8 more
wiley   +1 more source

Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial

, 2021
Nicholas J. Felicione, Jenny E. Ozga, Geri Dino, James H. Berry, C. Rolly Sullivan, Melissa D. Blank   +5 more
openalex   +2 more sources

Disentangling informing participants from obtaining their consent

Learning Health Systems, EarlyView.
Abstract Introduction Pragmatic clinical trials conducted in the context of routine care frequently satisfy the regulatory criteria for a waiver of research consent. When they do, investigators and Institutional Review Boards might assume that there is no reason to communicate any information regarding the study to participants.
Patricia Pearl O'Rourke, Joseph Ali, Judith Carrithers, David Magnus, Benjamin S. Wilfond, Sheana Bull, Laura M. Dember, Gail D'Onofrio, Julie Goldman, P. Michael Ho, Edward R. Melnick, Karen L. Staman, James A. Tulsky, Miguel A. Vazquez, Angelo Volandes, David Wendler   +15 more
wiley   +1 more source

EE317 Real-World Economic Benefit of Naloxone Use Among Illicit-Use Opioid Overdose Patients and Respiratory Comorbidity on Medication for Opioid Use Disorder (MOUD) [PDF]

, 2022
A Changolkar, G Owens, MK Sindhwani
openalex   +1 more source

The 730 nm Picosecond Titanium Sapphire Laser for Treatment of Kratom‐Induced Hyperpigmentation

Lasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives This case series reports the use of the 730‐nm picosecond titanium‐sapphire laser in the treatment of kratom‐induced hyperpigmentation, a dermatological side effect associated with the use of Mitragyna speciosa, which remains poorly understood. Methods A series of patients with kratom‐induced hyperpigmentation were treated using the
Alanoud A. Alhadyani, Christen Samaan, Girish S. Munavalli   +2 more
wiley   +1 more source